#Invention 003
OPTISON (Perflutren protein-Type A Microspheres Injectable Suspension, USP) is an FDA-approved ultrasound contrast agent available in a ready-to-use formulation, providing the benefits of fast preparation time, ease of use, portability, and dosing. It is the first contrast agent available in the United States to receive this contraindication label change.
It is sold by GE Healthcare.
Click here, to know more about it.















